Nemorexant

Unassigned

New Medicines

Insomnia in adults

Information

New molecular entity
Idorsia
Idorsia

Development and Regulatory status

None
Phase III Clinical Trials
Phase III Clinical Trials

Category

A dual orexin receptor antagonist
The Great British Sleep Survey (2011) identified that 45.7% of adults have insomnia disorder (28,092,168 people) [1].
Insomnia in adults
Oral